Opportunity Information: Apply for RFA MH 12 060
Apply for RFA MH 12 060
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Promoting Engagement in Care and Timely Antiretroviral Initiation Following HIV Diagnosis (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242 Mental Health Research Grants 93.279 Drug Abuse and Addiction Research Programs 93.856 Microbiology and Infectious Diseases Research.
- This funding opportunity was created on Jun 2, 2011 and posted on Jun 2, 2011.
- Applicants must submit their applications by Sep 9, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $3,000,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 8 candidate(s).
- Eligible applicants include: State governments Public housing authorities/Indian housing authorities Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) County governments Private institutions of higher education Small businesses For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Native American tribal governments (Federally recognized) City or township governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The National Institutes of Health (NIH) issued this R01 funding opportunity (RFA-MH-12-060) to support research focused on a very specific and high-impact window in HIV care: the first 12 months after someone is diagnosed with HIV, first enrolls in HIV primary care, and/or begins antiretroviral therapy (ART). The central idea is that early experiences with the healthcare system strongly shape whether a person links to care quickly, stays engaged, starts treatment when it is clinically indicated, and adheres well enough to reach viral suppression. NIH is looking for intervention research that directly tackles the practical and behavioral barriers that commonly slow down or disrupt these early steps.
The program’s priorities are framed around the HIV care continuum, with particular attention to (1) rapid linkage to medical care after diagnosis, (2) retention in care during the early phase of HIV primary care, and (3) readiness to voluntarily initiate ART and maintain adherence. In other words, this FOA is not just about getting people into a clinic once; it is about building and testing strategies that help newly diagnosed or newly connected patients navigate appointments, trust providers, manage stigma and disclosure concerns, address mental health and substance use challenges when relevant, and overcome structural obstacles such as transportation, insurance problems, housing instability, or competing life demands. The outcome NIH ultimately cares about is speeding the path from diagnosis to the first undetectable viral load for patients for whom ART is indicated, since viral suppression is a key marker of individual health and reduced transmission risk.
A second major theme is equity. The FOA explicitly calls for research that reduces racial and ethnic disparities in HIV treatment outcomes. That emphasis signals that NIH expects applicants to consider how interventions will work in real-world populations that have historically experienced worse outcomes due to unequal access to care, differential quality of care, stigma, poverty, and other systemic factors. Projects that are designed with the needs of disproportionately affected communities in mind, or that test approaches for closing gaps in early viral suppression and sustained engagement, align closely with the stated aims.
Administratively, this is a discretionary grant opportunity using the R01 mechanism, which generally supports substantial, hypothesis-driven research projects. The announcement listed an estimated total funding amount of $3,000,000 and anticipated making about 8 awards. It carried CFDA associations across mental health research grants (93.242), drug abuse and addiction research programs (93.279), and microbiology and infectious diseases research (93.856), which reflects NIH’s interest in interdisciplinary approaches, especially where mental health and substance use intersect with HIV care engagement and adherence.
The eligible applicant pool is broad and includes many types of domestic and non-domestic organizations. Eligible entities include state, county, city/township, and special district governments; public housing authorities and Indian housing authorities; public and private institutions of higher education; nonprofits with and without 501(c)(3) status; small businesses and other for-profit organizations; independent school districts; and tribal governments and tribal organizations, including federally recognized tribes. The eligibility language also highlights Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based and community-based organizations, regional organizations, U.S. territories and possessions, and foreign organizations and foreign institutions. It also allows non-U.S. components of U.S. organizations to apply. There is no cost sharing or matching requirement stated for this opportunity, reducing the barrier to participation for organizations that may not have large unrestricted funding sources.
Key dates in the source information indicate the FOA was posted and created on June 2, 2011, with an original and current closing date of September 9, 2011, and an archive date of October 10, 2011. NIH is the sponsoring agency, and the full announcement was hosted through the NIH grants guide (the provided link points to the official RFA page). For technical access issues, the contact listed is the NIH Office of Extramural Research (OER) Webmaster.
Overall, this opportunity is best understood as an NIH push to generate and rigorously test interventions that shorten delays and prevent drop-off at the earliest stages of HIV care, with success measured not only by clinic attendance or prescription fills, but by clinically meaningful endpoints like faster achievement of viral suppression and demonstrable reductions in disparities across racial and ethnic groups.
Frequently Asked Questions (FAQs)
What is this NIH funding opportunity (RFA-MH-12-060) about?
This NIH R01 opportunity supports intervention research focused on the first 12 months after a person is diagnosed with HIV, first enrolls in HIV primary care, and/or begins antiretroviral therapy (ART). The goal is to test strategies that reduce early delays and drop-off in HIV care and improve clinically meaningful outcomes, especially faster achievement of an undetectable viral load when ART is indicated.
What phase of HIV care is the FOA targeting?
The FOA targets the early window of HIV care: the initial year after diagnosis, initial connection to HIV primary care, and/or ART initiation. It emphasizes that early healthcare experiences can strongly influence rapid linkage to care, retention, readiness to start treatment, and adherence that supports viral suppression.
What are the main priority areas within the HIV care continuum?
The priorities are framed around: (1) rapid linkage to medical care after diagnosis, (2) retention in care during the early phase of HIV primary care, and (3) readiness to voluntarily initiate ART and maintain adherence.
Is this opportunity only about getting patients to attend one clinic visit?
No. The FOA is explicitly about building and testing strategies that help newly diagnosed or newly connected patients successfully navigate the early steps of HIV care over time, including staying engaged, initiating treatment when clinically indicated, and adhering well enough to reach viral suppression.
What kinds of barriers is NIH expecting interventions to address?
The FOA highlights practical and behavioral barriers that can slow or disrupt early HIV care, including challenges with navigating appointments, building trust with providers, stigma and disclosure concerns, mental health and substance use challenges (when relevant), and structural obstacles such as transportation, insurance problems, housing instability, and competing life demands.
What outcomes does NIH ultimately care about for this FOA?
The FOA emphasizes speeding the path from HIV diagnosis to the first undetectable viral load for patients for whom ART is indicated. Viral suppression is framed as a key marker of individual health and reduced transmission risk. The FOA also signals that success is not only measured by process metrics (like visits or prescriptions) but by clinically meaningful endpoints such as viral suppression.
Does the FOA include an equity or disparities focus?
Yes. A major theme is reducing racial and ethnic disparities in HIV treatment outcomes. The FOA explicitly calls for research designed to reduce these disparities and expects applicants to consider how interventions will work in real-world populations that have historically experienced worse outcomes due to unequal access to care, differential quality of care, stigma, poverty, and other systemic factors.
What types of projects align well with the FOA’s equity emphasis?
Projects designed with the needs of disproportionately affected communities in mind, or that test approaches for closing gaps in early viral suppression and sustained engagement in care, align closely with the stated aims.
What grant mechanism is being used?
This is a discretionary grant opportunity using the NIH R01 mechanism, which generally supports substantial, hypothesis-driven research projects.
How much funding is expected to be available, and how many awards were anticipated?
The announcement listed an estimated total funding amount of $3,000,000 and anticipated about 8 awards.
Which CFDA program areas are associated with this opportunity?
The FOA lists CFDA associations across: mental health research grants (93.242), drug abuse and addiction research programs (93.279), and microbiology and infectious diseases research (93.856). This reflects NIH’s interest in interdisciplinary approaches, particularly where mental health and substance use intersect with HIV care engagement and adherence.
Who is eligible to apply?
The eligible applicant pool is broad and includes domestic and non-domestic organizations. Eligible entities include state, county, city/township, and special district governments; public housing authorities and Indian housing authorities; public and private institutions of higher education; nonprofits with and without 501(c)(3) status; small businesses and other for-profit organizations; independent school districts; and tribal governments and tribal organizations, including federally recognized tribes.
Are community-based and faith-based organizations included in eligibility?
Yes. The eligibility language highlights faith-based and community-based organizations among eligible entities.
Are minority-serving institutions specifically mentioned as eligible?
Yes. The eligibility language highlights Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs).
Can foreign organizations apply?
Yes. The eligibility language includes foreign organizations and foreign institutions, and it also allows non-U.S. components of U.S. organizations to apply.
Are U.S. territories and possessions included?
Yes. The eligibility language includes U.S. territories and possessions.
Is cost sharing or matching required?
No cost sharing or matching requirement is stated for this opportunity.
When was the FOA posted, and what were the key dates?
The source information indicates the FOA was posted and created on June 2, 2011. The original and current closing date is listed as September 9, 2011, and the archive date is October 10, 2011.
Who is the sponsoring agency?
The sponsoring agency is the National Institutes of Health (NIH).
Where was the full announcement hosted?
The full announcement was hosted through the NIH grants guide, with a link pointing to the official RFA page.
Who is the contact for technical access issues?
For technical access issues, the contact listed is the NIH Office of Extramural Research (OER) Webmaster.
What is the overall intent of this opportunity in plain terms?
Overall, the FOA reflects an NIH push to generate and rigorously test interventions that shorten delays and prevent drop-off at the earliest stages of HIV care, with success measured by clinically meaningful outcomes (like faster viral suppression) and by demonstrable reductions in racial and ethnic disparities.
Browse more opportunities from the same category: Education Health
Next opportunity: Promoting Engagement in Care and Timely Antiretroviral Initiation Following HIV Diagnosis (R34)
Previous opportunity: Collaborative Interdisciplinary Team Science in NIDDK Research Areas (R24)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA MH 12 060
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA MH 12 060) also looked into and applied for these:
| Funding Opportunity |
|---|
| Promoting Engagement in Care and Timely Antiretroviral Initiation Following HIV Diagnosis (R34) Apply for RFA MH 12 061 Funding Number: RFA MH 12 061 Agency: National Institutes of Health Category: Education Health Funding Amount: $225,000 |
| High End Instrumentation Grant Program (S10) Apply for PAR 11 228 Funding Number: PAR 11 228 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Limited Competition Institutional Development Award (IDeA) Program Infrastructure for Clinical and Translational Research IDeA CTRU54 Apply for PAR 11 229 Funding Number: PAR 11 229 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Epidemiology of Drug Abuse (R01) Apply for PA 11 230 Funding Number: PA 11 230 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Epidemiology of Drug Abuse (R21) Apply for PA 11 231 Funding Number: PA 11 231 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Epidemiology of Drug Abuse (R03) Apply for PA 11 232 Funding Number: PA 11 232 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Probes for Microimaging The Nervous System (SBIR R43/R44) Apply for PA 09 062 Funding Number: PA 09 062 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA MH 12 060", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.